3 March 2020

The Radboudumc in cooperation with the ErasmusMC, University Hospital Leuven, HCM Medical and several patient organizations has been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM).

The 6-year project is based on an advanced collagen-based plug and includes a clinical trial. At Radboudumc, Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt (all theme Reconstructive & and regenerative medicine), and Janneke Grutters (theme Urological Cancers) are involved.

Minimal fetal surgery using endoscopy is a promising medical technology to treat children before birth, e.g. children with rare diseases like congenital diaphragmatic hernia, twin-to-twin transfusion syndrome or spina bifida. During endoscopy, the fetal membranes are punctured, which introduces a significant risk of membrane rupture and subsequent premature birth, and is considered the achilles heel of fetoscopic surgery. The plug is anticipated to close the membranes at the endoscopic entry point thus preventing amniotic fluid leakage and associated severe complications.
 

Related news items


Turbo Grants for four medical-technical research projects

19 October 2021 Four TURBO grants were recently awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between the University of Twente (TechMed Centre) and the Radboudumc. read more

Millions of euros for study of laser treatment for glioblastoma

2 April 2021 A research group from Radboudumc and UMC Utrecht is to investigate laser treatment of a rare brain tumor, glioblastoma. 3.9 million euros has been made available for the research by Zorginstituut Nederland and ZonMw, under the auspices of the Subsidy Scheme for Promising Care. read more

Grant for early detection of ovarian cancer

5 June 2020 The Department of Biochemistry (Toin van Kuppevelt/Willeke Daamen), together with the Department of Gynecology, has been awarded a grant of 144 kEuro for the development of an assay for the early detection of ovarian cancer. read more

Differences in the placental disposition of TNF inhibitors uncovered

19 March 2020 In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept. read more

FET-OPEN grant for Toin van Kuppevelt and Willeke Daamen

6 March 2020 A grant of 592 kEuro has been awarded to Toin van Kuppevelt and Willeke Daamen, theme Reconstructive and regenerative medicine, for a Horizon 2020 FET-OPEN project entitled “Heparin and heparan sulphate: from sequence determination to therapeutic strategies for Parkinson’s disease”. read more

Four Veni grants for young Radboudumc researchers

28 July 2017 Four researchers from Radboudumc have been awarded a Veni grant the Netherlands Organisation for Scientific Research (NWO). These grants provide highly promising young scientists with the opportunity to further elaborate their own ideas during a period of three years. read more